You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recombinant Human Hyaluronidase

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Metastatic Pancreatic Adenocarcinoma Trial in United States (PEGPH20, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Anchorage, Alaska
  • +153 more
Nov 29, 2021

Platelet Membrane Cloaked Recombinant Staphylokinase on Human

Not yet recruiting
  • Arterial Thrombosis
  • collection of venous blood or arterial blood
  • (no location specified)
Aug 6, 2023

PEGylated GH for Treatment of Short Stature in Chinese

Recruiting
  • Growth Hormone Treatment
  • Growth Disorders
  • Polyethylene glycol recombinant human growth hormone injection
  • Beijing, Beijing, China
    Department of Endocrinology, Genetics, Metabolism
Sep 12, 2023

Phelan-McDermid Syndrome, Growth Hormone Treatment Trial in Wuxi (recombinant human growth hormone, Saline)

Completed
  • Phelan-McDermid Syndrome
  • Growth Hormone Treatment
  • recombinant human growth hormone
  • Saline
  • Wuxi, Jiangsu, China
    Affiliated Hospital of JiangNan University, Department of Pediat
Oct 7, 2022

Colorectal Tumors Trial (Envafolimab, recombinant human endostatin (endostatin))

Not yet recruiting
  • Colorectal Neoplasms
  • (no location specified)
Sep 19, 2022

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

NSCLC, Gastric Cancer Trial in United States (PEGPH20, Pembrolizumab)

Completed
Has Results
  • NSCLC
  • Gastric Cancer
  • Birmingham, Alabama
  • +27 more
Jan 24, 2020

Healthy Trial in Groningen (Milvexian, 4-Factor Prothrombin Complex Concentrate (4F-PCC), Recombinant Human Factor VIIa

Recruiting
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Jan 3, 2023

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

Not yet recruiting
  • Idiopathic CD4 Lymphopenia
  • Recombinant human interleukin (IL) 7-hyFc
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Sepsis, Thrombocytopenia Trial in Shanghai (rhTPO, Placebo)

Recruiting
  • Sepsis
  • Thrombocytopenia
  • Shanghai, Shanghai, China
    Shanghai General Hospital, Shanghai Jiaotong University
Oct 25, 2022

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil

Recruiting
  • Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
  • 5-Fluorouracil (5-FU)
  • +11 more
  • Scottsdale, Arizona
  • +41 more
Jan 19, 2023

Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 17, 2022

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

Assessment of Recombinant HAT-RDT Specificity

Recruiting
  • Human African Trypanosomiasis
    • Kinshasa, Congo, The Democratic Republic of the
      Programme National de Lutte contre la Trypanosomiase Humaine Afr
    Nov 24, 2022

    Purpura, Schoenlein-Henoch Trial in Changchun (IL-2)

    Completed
    • Purpura, Schoenlein-Henoch
    • Changchun, Changchun/JiLin, China
      Sirui Yang
    Aug 16, 2022

    Healthy Trial in Qingdao (VDJ001, Placebo)

    Completed
    • Healthy
    • Qingdao, Shandong, China
      the Affliated Hospital of Qingdao University
    Aug 30, 2023

    Hemophilia A, Hemophilia B Trial in China (Recombinant human activated coagulation factor VII for injection)

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Recombinant human activated coagulation factor VII for injection
    • Chongqing, Chongqing, China
    • +8 more
    Aug 2, 2022

    Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical

    Not yet recruiting
    • Ischemic Stroke, Acute
    • Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
    • Best Medical Management
    • (no location specified)
    Nov 24, 2022

    Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

    Not yet recruiting
    • Cholangiocarcinoma, Intrahepatic
    • Recombinant Human Adenovirus Type 5
    • HAIC of FOLFOX
    • Beijing, Beijing, China
      Beijing Tsinghua Chang Gung Hospital
    Mar 16, 2022

    Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia Trial

    Not yet recruiting
    • Chronic Lung Disease of Prematurity
    • +2 more
    • Recombinant fragment of human surfactant protein D (rfhSP-D)
    • (no location specified)
    Jun 6, 2023

    Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

    Completed
    Has Results
    • Adult T-Cell Lymphoma/Leukemia
    • +2 more
    • Recombinant human Interleukin-15 (rhIL-15)
    • Mogamulizumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 9, 2022